Showing results (411-420 of 498) with videos related to
Sort By:
Pageof 50
Journal of Pain and Symptom Management|November 30, 2025
Palliative Care in Low and Middle-Income Countries to Reduce Cancer Suffering: A Systematic ReviewShrikant Atreya, Mebin Mathew, Vijay Shree Dhyani, et al.BMJ Open|December 27, 2023
ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocolAjay Aggarwal, Laurence Edward Court, Peter Hoskin, et al.The Lancet. Oncology|November 5, 2025
The human crisis in cancer: a Lancet Oncology CommissionGary Rodin, Amalya Feldman, Dario Trapani, et al.Pain Practice : the Official Journal of World Institute of Pain|March 26, 2021
ECAP-Controlled Closed-Loop Spinal Cord Stimulation Efficacy and Opioid Reduction Over 24-Months: Final Results of the Prospective, Multicenter, Open-Label Avalon StudyCharles Brooker, Marc Russo, Michael J Cousins, et al.Journal of Cellular Biochemistry|August 10, 2007
Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migrationLynne-Marie Postovit, Daniel E Abbott, Stacey L Payne, et al.Thorax|March 8, 2018
Geographical variations in the use of cancer treatments are associated with survival of lung cancer patientsHenrik Møller, Victoria H Coupland, Daniela Tataru, et al.BMJ Global Health|November 7, 2024
Building resilient surgical systems that can withstand external shocksJames C Glasbey, Adesoji O Ademuyiwa, Kathryn Chu, et al.The Lancet. Oncology|March 13, 2019
Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer careC S Pramesh, Harit Chaturvedi, Vijay Anand Reddy, et al.Malaria Journal|February 11, 2017
Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in UgandaIsaac Ssewanyana, Emmanuel Arinaitwe, Joaniter I Nankabirwa, et al.Journal of Cancer Policy|June 19, 2022
Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancerRaymond H Henderson, Declan French, Ethna McFerran, et al.Pageof 50